Meral Günaldı

• Licence : Faculté de médecine, Université technique du Mar Black Sea (1994-2001)
• Spécialisation en médecine : Médecine interne, Hôpital universitaire d'Okmeydanı (2004-2009)
• Spécialisation secondaire : Oncologie médicale, Faculté de médecine de l'Université Çukurova (2009-2013)
• Maîtrise : Médecine interne, Université Acıbadem (2016)
• Professeur : Université Aydın d'Istanbul (2022)
  

• 2001-2002 : Village de Göçgün Demirci, Bartın, Centre de santé de Kozcağız (médecin généraliste)
  2002-2003 : Faculté de médecine de l'université d'Istanbul, département de neurologie (assistant)
  2004-2009 : Hôpital universitaire d'Okmeydanı, médecine interne (assistant)
  2009-2013 : Faculté de médecine de l'université Çukurova, oncologie médicale (assistant)
  2013-2016 : Hôpital universitaire Dr. Sadi Konuk de Bakırköy, Istanbul (spécialiste en oncologie médicale)
  2016-2018 : Centre médical privé Neolife (maître de conférences)
  2017-2023 : Faculté de médecine de l'université Aydın d'Istanbul, hôpital Florya Medical Park (maître de conférences/professeur)
  2023-2025 : Hôpital Medicana Ataköy (professeur, spécialiste en oncologie médicale)
  2025-... : Hôpital Liv Ulus
  

• Günaldi, M., Helvaci, A., Yildirim, N. D., Kiskaç, M., & Küçükkaya, R. D. (2009). Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. Cardiology Journal, 16(5), 458–461.
• Duman, B. B., Kara, I. O., Günaldi, M., & Erçolak, V. (2011). Primary cutaneous small-cell carcinoma: A case report. Medical Oncology, 28(Suppl 1), S634–S635. https://doi.org/10.1007/s12032-010-9672-3
• Duman, B. B., Kara, I. O., Günaldi, M., & Ercolak, V. (2011). Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Archives of Gynecology and Obstetrics, 283(6), 1363–1368. https://doi.org/10.1007/s00404-011-1845-6
• Gunaldi, M., Helvaci, A., Demirel Yildirim, N., Aydin, D., & Kara, N. (2011). Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. Journal of BUON, 16(4), 778.
• Günaldi, M., Oguz Kara, I., Duman, B. B., & Gumurdulu, D. (2012). Primary intrapulmonary thymoma associated with myasthenia gravis. General Thoracic and Cardiovascular Surgery, 60(9), 610–613. https://doi.org/10.1007/s11748-012-0064-9
• Duman, B. B., Paydas, S., Tetiker, T., Gunaldı, M., Afsar, C. U., Erçolak, V., Haksöyler, V., & Dilli, M. Ş. (2012). Capecitabine-induced hypertriglyceridemia and hyperglycemia: Two cases. Pharmacology, 90(3–4), 212–215. https://doi.org/10.1159/000342382
• Duman, B. B., Afşar, Ç. U., Günaldi, M., Sahin, B., Kara, I. O., Erkisi, M., & Erçolak, V. (2012). Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pacific Journal of Cancer Prevention, 13(8), 4119–4123.
• Duman, B. B., Gunaldi, M., Ercolak, V., Afsar, C. U., Sahin, B., Erkisi, I. M., Kara, O., Paydas, S., Gönlüsen, G., & Sertdemir, Y. (2012). Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. Asian Pacific Journal of Cancer Prevention, 13(8), 4125–4128.
• Gunaldi, M., Kara, I. O., Duman, B. B., & Ercolak, V. (2012). Primary intracerebral myeloid sarcoma. Onkologie, 35(11), 694–697. https://doi.org/10.1159/000343953
• Günaldi, M., Paydas, S., & Afsar, C. U., & Doran, F. (2013). Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Medical Journal, 54(11), e233–e235.
• Günaldı, M., Paydaş, S., Usul Afşar, C., Bozkurt Duman, B., & Erçolak, V., Haksöyler, V. (2013). Carbamazepine and multiple myeloma: Possible interaction. Turkish Journal of Haematology, 30(1), 83–84. https://doi.org/10.4274/tjh.2012.0153
• Usul Afşar, C., Paydaş, S., Günaldı, M., Bozkurt Duman, B., Erçolak, V., Zorludemir, S., & Açıkalın, A. (2013). Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: Curious lymphocyte/neutrophil fluctuations. Turkish Journal of Haematology, 30(4), 413–415. https://doi.org/10.4274/Tjh.2012.0055
• Erçolak, V., Kara, O., Günaldı, M., Usul Afşar, C., Bozkurt Duman, B., Açıkalın, A., Ergin, M., & Erdoğan, S. (2014). Bilateral primary adrenal non-Hodgkin lymphoma. Turkish Journal of Haematology, 31(2), 205–206. https://doi.org/10.4274/tjh.2013.0195
• Gunaldi, M., Kara, I. O., Duman, B. B., Afsar, C. U., Ergin, M., & Avci, A. (2014). A new approach to the treatment of metastatic paraganglioma: Sorafenib. Cancer Research and Treatment, 46(4), 411–414.
• Sözütek, D., Yanık, S., Akkoca, A. N., Sözütek, A., Ozdemir, Z. T., Avşar, C. U., Günaldı, M., Sahin, B., & Doron, F. (2014). Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. International Journal of Clinical and Experimental Medicine, 7(7), 1914–1922.
• Ercolak, V., Paydas, S., Ergin, M., Ates, B. T., Duman, B. B., Gunaldi, M., & Afsar, C. U. (2014). Abdominal actinomycosis with multiple myeloma: A case report. Oncology Letters, 8(4), 1876–1878.
• Paydaş, S., Ozdoğu, H., Günaldı, M., Haksöyler, V., Açıkalın, A., & Ergin, M. (2014). Extramedullary myeloid tumor involving the pancreas: A case report and review of the literature. Turkish Journal of Haematology, 31(3), 295–300. https://doi.org/10.4274/tjh.2013.0195
• Günaldı, M., Erkisi, M., Afşar, C. U., Erçolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U. K., & Secilmis, A. (2014). Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology, 94(3–4), 183–189.
• Afsar, C. U., Gunaldi, M., Kum, P., Sahin, B., Erkisi, M., Kara, I. O., Paydas, S., Duman, B. B., Ercolak, V., Karaca, F., Uyeturk, U., & Guner, S. I. (2014). Pancreatic carcinoma, thrombosis and mean platelet volume: Single center experience from the southeast region of Turkey. Asian Pacific Journal of Cancer Prevention, 15(21), 9143–9146.
• Gunaldi, M., Duman, B. B., Afsar, C. U., Paydas, S., Erkisi, M., Kara, I. O., & Sahin, B. (2016). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Journal of Oncology Pharmacy Practice, 22(2), 242–247.
• Karaca, F., Afsar, C. U., Gunaldi, M., Erkurt, E., Ercolak, V., Sertdemir, Y., & Paydas, S. (2015). Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. International Journal of Clinical and Experimental Medicine, 8(1), 876–882.
• Okuturlar, Y., Gunaldi, M., Tiken, E. E., Oztosun, B., Inan, Y. O., Ercan, T., Tuna, S., Kaya, A. O., Harmankaya, O., & Kumbasar, A. (2015). Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pacific Journal of Cancer Prevention, 16(6), 2409–2412.
• Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbasi, A., Kocoglu, H., Kural, A., Akarsu, C., Gunduz, U., & Tiken, E. E. (2015). Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku Journal of Experimental Medicine, 236(2), 97–102. https://doi.org/10.1620/tjem.236.97
• Ercolak, V., Paydas, S., Bagir, E., Ergin, M., Seydaoglu, G., Celik, H., Yavu, B., Tanriverdi, K., Gunaldi, M., Afsar, C. U., & Duman, B. B. (2015). PRAME expression and its clinical relevance in Hodgkin's lymphoma. Acta Haematologica, 134(4), 199–207.
• Gunaldi, M., Goksu, S., Erdem, D., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., Inan, Y. O., Genc, T. B., & Yildirim, M. (2015). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study. International Journal of Clinical and Experimental Medicine, 8(4), 5937–5942.
• Günaldı, M., Afsar, C. U., Duman, B. B., Kara, I. O., Tatli, U., & Sahin, B. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters, 10(1), 439–442.
• Karabulut, M., Gunaldi, M., Alis, H., Afsar, C. U., Karabulut, S., Serilmez, M., Akarsu, C., Seyit, H., & Aykan, N. F. (2016). Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clinical and Translational Oncology, 18(2), 160–171.
• Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Mert, M., Harmankaya, O., Soylu, A., Karakaya, P., & Kumbasar, A. (2016). Serum paraoxonase 1 activity in patients with iron deficiency anemia. Archives of Medical Science, 12(4), 697–703. https://doi.org/10.5114/aoms.2015.48730
• Okuturlar, Y., Ozkalemkas, F., Ener, B., Serin, S. O., Kazak, E., Ozcelik, T., Ozkocaman, V., Ozkan, H. A., Akalin, H., Gunaldi, M., & Ali, R. (2015). Serum galactomannan levels in the diagnosis of invasive aspergillosis. Korean Journal of Internal Medicine, 30(6), 899–905.
• Ercolak, V., Sahin, B., Gunaldi, M., Duman, B. B., & Afsar, C. U. (2015). Efficacy of paclitaxel in the treatment of Kaposi sarcoma. European Review for Medical and Pharmacological Sciences, 19(21), 4095–4100.
• Usul Afsar, C., Sahin, B., Gunaldi, M., Kılıc Bagir, E., Gumurdulu, D., Burgut, R., Erkisi, M., Kara, I. O., Paydas, S., Karaca, F., & Ercolak, V. (2015). Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in squamous cell carcinoma of the lung. International Journal of Clinical and Experimental Pathology, 8(9), 9760–9771.
• Gunaldi, M., Okuturlar, Y., Gedikbasi, A., Akarsu, C., Karabulut, M., & Kural, A. (2015). Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomedicine & Pharmacotherapy, 76, 52–56. https://doi.org/10.1016/j.biopha.2015.10.029
• Karabulut, M., Alis, H., Bas, K., Karabulut, S., Afsar, C. U., Oguz, H., Gunaldi, M., Akarsu, C., Kones, O., & Aykan, N. F. (2015). Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Molecular and Clinical Oncology, 3(6), 1255–1267.
• Gunaldi, M., Kocoglu, H., Okuturlar, Y., Gedikbasi, A., Karabulut, M., & Hursitoglu, M. (2015). Heat shock protein 70 is a useful marker for predicting colorectal cancer. Journal of BUON, 20(6), 1464–1470.
• Afsar, C. U., Gunaldı, M., Okuturlar, Y., Gedikbası, A., Tiken, E. E., Kahraman, S., Karaca, F., Ercolak, V., & Karabulut, M. (2015). Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. International Journal of Clinical and Experimental Medicine, 8(11), 21599–21604.
• Ekmen, N., Helvaci, A., Gunaldi, M., Sasani, H., & Yildirmak, S. T. (2016). Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart Journal, 68(2), 132–137. https://doi.org/10.1016/j.ihj.2015.07.032
• Kocoglu, H., Dogan, H., Oguz, B., Ocak Serin, S., Okuturlar, Y., Gunaldi, M., Erismis, B., Ozdemir, B., Tural, D., Hursitoglu, M., Harmankaya, O., & Kumbasar, A. (2016). Comparison of survival rates, tumor stages, and localization in obese and nonobese patients with gastric cancer. Gastroenterology Research and Practice, 2016, 9382750. https://doi.org/10.1155/2016/9382750
• Gündüz, U. R., Gunaldi, M., Isiksacan, N., Gündüz, S., Okuturlar, Y., & Kocoglu, H. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Molecular and Clinical Oncology, 5(2), 355–360.
• Tanriverdi, O., Menekse, S., Teker, F., Oktay, E., Nur Pilanc, K., Gunaldi, M., Kocar, M., Kacan, T., Bahceci, A., Avci, N., Akman, T., Cokmert, S., Yesil-Cinkir, H., & Teoman Yanmaz, M. (2016). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: A retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). Journal of BUON, 21(4), 840–850.
• Gunaldi, M., Kose, F., Demirci, N. S., Gunduz, S., Ozdemir, N., Kocoglu, H., Okuturlar, Y., Sedef, A. M., Erdem, D., Goksu, S. S., Erdem, G. U., & Yildirim, M. (2018). Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective multicenter study. Journal of BUON, 23(2), 416–421.
• Gunaldi, M., Isiksacan, N., Kocoglu, H., Okuturlar, Y., Gunaldi, O., Topcu, T. O., & Karabulut, M. (2018). The value of serum survivin level in early diagnosis of cancer. Journal of Cancer Research and Therapeutics, 14(3), 570–573.
• Topcu, T. O., Ozdemir, F., Kavgaci, H., Gunaldi, M., Kocoglu, H., Imamoglu, G. I., Mentese, A., Yaman, S. O., Orem, A., & Aydin, F. (2018). The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer. Journal of Cancer Research and Therapeutics, 14(3), 608–613.
• Okuturlar, Y., Gunaldi, M., Kocoglu, H., Hursitoglu, M., Gedikbasi, A., Acarer, D., Harmankaya, O., & Kumbasar, A. (2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. Journal of Cancer Research and Therapeutics, 14(Suppl), S362–S367.
• Şişman, H., Özgen, R., Baysal, D., Sarıakçalı, N., Öztürk, S., Kum, P., Gürel, D., Kanarığ, D., Aslaner, E., Akıl, Y., & Günaldı, M. (2014). Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey. Asia-Pacific Journal of Oncology Nursing, 1(1), 40–45.
• Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The lifetime cost-of-disease (CoD) of metastatic colorectal cancer (mCRC) in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A448.
• Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-of-disease of metastatic/inoperable gastrointestinal stromal tumors in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A449.
• Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of metastatic/inoperable gastrointestinal stromal tumors in Turkey. Value in Health, 18(7), A455.
• Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer (mCRC) who have progressed after standard therapies in Turkey. Value in Health, 18(7), A458.
• Gunaldi, M., Erdem, D., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Aksoy, H., & Yildirim, M. (2016). Platelet distribution width as a predictor of metastasis in gastric cancer patients. Journal of Gastrointestinal Cancer. Advance online publication. https://doi.org/10.1007/s12029-016-9886-5
• Demir, A., Molinas Mandel, N., Paydas, S., Demir, G., Er, O., Turhal, N. S., Bavbek, S., Eralp, Y., Saip, P. M., Güler, E. N., Aydıner, A., Uluç, B. O., Kılıçkap, S., Üskent, N., Karadurmuş, N., Kaplan, M. A., Yanmaz, M. T., Demir, H., Alan, O., Korkmaz, T., Olgun, P., Uysal, Ö. S., Altundağ, K., Gündüz, Ş., Günaldı, M., Sarı, M., Beypınar, İ., & Başaran, G. (2020). [Article title unavailable]. Balkan Medical Journal, 37(2), 104–107. https://doi.org/10.4274/balkanmedj.galenos.2020.2020.2.3

Communications Présentées lors de Réunions Scientifiques Internationales et Publiées dans les Actes (Proceedings):

• Gunaldi, M., Kara, I. O., Afsar, C. U., & Duman, B. B. (2012, June 1–5). Sorafenib in the treatment of metastatic paraganglioma: A case report [Présentation par Affiche]. 2012 ASCO Annual Meeting, Chicago, IL, United States.
• Duman, B. B., Gunaldi, M., Tasdogan, B. E., Afsar, C. U., Paydas, S., & Gumurdulu, Y. (2012, May–June). Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer [Présentation par Affiche]. ASCO Annual Meeting, Chicago, IL, United States.
• Gunaldi, M., Sahin, B., & Tatlı, U. (2011). Osteonecrosis of the jaw in cancer patients treated with bisphosphonates [Présentation par Affiche]. Mediterranean Multidisciplinary Oncology Forum Congress.
• Tiken, E. E., Günaldı, M., Okuturlar, Y., & Tuna, S. (2014, September 30–October 2). The evaluation of synchronous bilateral breast cancer patients [Présentation par Affiche]. International Breast Cancer Conference, Istanbul, Turkey.
• Okuturlar, Y., Günaldı, M., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014, September 30–October 2). Evaluation of body mass index in breast cancer patients [Présentation par Affiche]. International Breast Cancer Conference, Istanbul, Turkey.
• Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014, September 30–October 2). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Présentation par Affiche]. International Breast Cancer Conference, Istanbul, Turkey.
• Gunaldi, M., Erkisi, M., Afsar, C. U., Ercolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U., & Secilmis, A. (2014). The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment [Présentation par Affiche]. ASCO Annual Meeting, Chicago, IL, United States.
• Afsar, C. U., Sahin, B., Gumurdulu, D., Kılıc Bagir, E., Burgut, R., Erkisi, M., Kara, I. O., Gunaldi, M., & Ercolak, V. (2014, September 26–30). The evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGF2), phosphatidylinositol 3 phosphate kinase (IP3K) expression and their clinical, prognostic significance in early and advanced stage of squamous cell carcinoma of the lung [Présentation par Affiche]. 39th ESMO Congress, Madrid, Spain.
• Helvaci, A., Çorbacıoğlu, E., & Günaldı, M. (2010, April 15–18). Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug [Présentation par Affiche]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
• Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Karakaya, P., Mert, M., & Harmankaya, O. (2014, June 22–26). Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia [Présentation par Affiche]. IFCC WorldLab Istanbul 2014, 22nd International Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.
• Afsar, C. U., Gunaldi, M., Okuturlar, Y., Gedikbaşı, A., & Kural, A. (2014). Paraoxonase and arylesterase activities in patients with colorectal cancer [Présentation par Affiche]. Advances in Predictive & Personalized Medicine.
• Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbaşı, A., Kural, A., & Tiken, E. E. (2014). Can heat shock protein 70 be a target therapy in breast cancer? [Présentation par Affiche]. Advances in Predictive & Personalized Medicine.
• Okuturlar, Y., Gunaldi, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2014). Breast cancer and paraoxonase activity [Présentation par Affiche]. Advances in Predictive & Personalized Medicine.
• Isıksacan, N., Koşer, M., Gunaldi, M., & Ördekçi, S. (2014). C-reactive protein (CRP) measurement using point of care (POC) devices [Présentation par Affiche]. Advances in Predictive & Personalized Medicine.
• Oztosun, B., Okuturlar, Y., Gunaldi, M., Soyluk, S., Biricik, Ö., Mert, M., Sayilan, S., Orman, M., & Kaptanoğulları, Ö. (2014). An aggressive malignant insulinoma: A case report [Présentation par Affiche]. European Congress of Endocrinology.
• Abbasoğlu, D., Gunaldi, M., Sivas, H., Yakıcıer, M. C., & Hızel, H. C. (2014). The factors affecting UGT1A1 enzyme activity of irinotecan drug response in Turkish population [Présentation par Affiche]. 7th Santorini Conference on Systems Personalized Health and Therapy.
• Gunaldi, M., & Helvaci, A. (2010, April 15–18). Alteration in serum levels of selenium and glutathione peroxidase in acute myocardial infarction [Présentation par Affiche]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
• Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Présentation par Affiche]. International Breast Cancer Conference, Istanbul, Turkey.
• Okuturlar, Y., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014). Evaluation of body mass index in breast cancer patients [Présentation par Affiche]. International Breast Cancer Conference, Istanbul, Turkey.
• Günaldı, M., Gürgenyataği, D., Göksu, S., Gülenay, Ş., Yildirim, M., Tiken, E., Okuturlar, Y., & Kahraman, S. (2014). A factor that predicts occurrence of metastasis on stomach cancer patients: PDW [Présentation par Affiche]. 4th International Gastrointestinal Cancer Conference.
• Okuturlar, Y., Günaldı, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2015). Breast cancer and paraoxonase activity [Présentation par Affiche]. Cancer International Symposium on Advances in Predictive & Personalized Medicine.
• Gunaldi, M., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., & Isıksacan, N. (2015, September 6–9). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study [Présentation par Affiche]. 4th European Congress of Immunology, Vienna, Austria.
• Gunaldi, M., Okuturlar, Y., Kural, A., Akarsu, C., Karabulut, M., & Gedikbasi, A. (2015, September 6–9). Clinical importance of S100A9 and S100A12 in breast cancer [Présentation par Affiche]. 4th European Congress of Immunology, Vienna, Austria.
• Gunaldi, M., Isıksacan, N., Okuturlar, Y., Kocoglu, H., & Gunaldi, O. (2015, September 6–9). Clinical significance of serum survivin in cancer patients [Présentation par Affiche]. 4th European Congress of Immunology, Vienna, Austria.

Livres Nationaux/Internationaux Rédigés ou Chapitres de Livres:

• Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite (Classification, utilisation et toxicité dans la chimiothérapie et les thérapies ciblées moléculaires). In H. Onat (Ed.), Kanser kemoterapi el kitabı (Manuel de chimiothérapie anticancéreuse). Çukurova Nobel Kitabevi. (Chapitre de Livre)
• Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı (Réservoir d'Ommaya). In Nöroşirurjide şant cerrahisi (Chirurgie de shunt en neurochirurgie). Selen Yayıncılık. (Chapitre de Livre)

Livres Nationaux/Internationaux Rédigés:

• Günaldı, M. (2022, Février). Gastrointestinal sistem kanserlerinde güncel yaklaşımlar – Metastatik iyi farklılaşmış gastrointestinal ve pankreas nöroendokrin tümörlerde tedavi (Approches actuelles dans les cancers du système gastro-intestinal – Traitement des tumeurs neuroendocrines pancréatiques et gastro-intestinales métastatiques bien différenciées). (Livre)
• Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı (Réservoir d'Ommaya). In Nöroşirurjide şant cerrahisi (Chirurgie de shunt en neurochirurgie). Selen Yayıncılık. (Livre)
• Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite (Classification, utilisation et toxicité dans la chimiothérapie et les thérapies ciblées moléculaires). In H. Onat (Ed.), Kanser kemoterapi el kitabı (Manuel de chimiothérapie anticancéreuse). Çukurova Nobel Kitabevi. (Livre)

Articles Publiés dans des Revues Nationales à Comité de Lecture:

• Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Kara, İ. O., & Şahin, B. (2012). Sorafenib ilişkili üç farklı deri toksisitesi: Olgu sunumu (Trois toxicités cutanées différentes liées au sorafénib : Rapport de cas). Turkish Journal of Dermatology.
• Yılmaz, G., Adaş, M., Helvacı, A., Altıntaş, N., & Günaldi, M. (2013). Evaluation of respiratory functions in subclinical and clinical hypothyroidism. Journal of Turgut Ozal Medical Center.
• Tiken, E. E., Günaldi, M., Okuturlar, Y., & Sever, N. (2014). İnvaziv lobuler meme kanserinin mideye metastazı: Olgu sunumu (Métastase du cancer du sein lobulaire invasif à l'estomac : Rapport de cas). Türk Onkoloji Dergisi, 29(4), 157–161. https://doi.org/10.5505/tjoncol.2014.1178
• Günaldi, M., Duman, B. B., Afşar, Ç. U., Günaldı, Ö., & Şahin, B. (2014). Temporal kemik yerleşimli langerhans hücreli histiositozis: Bir olgu sunumu (Histiocytose à cellules de Langerhans localisée à l'os temporal : Un rapport de cas). Göztepe Tıp Dergisi.
• Karaca, F., Erçolak, V., Afşar, Ç. U., & Günaldi, M. (2015). Memenin diffüz büyük B hücreli lenfoması (Lymphome diffus à grandes cellules B du sein). Çukurova Medical Journal.
• Günaldi, M., & Köksal Erkiş, M. (2014). Glioblastome multiformede kemoterapi (Chimiothérapie dans le glioblastome multiforme). Klinik Tıp Bilimleri.
• Gözkaman, A., Okuturlar, Y., Kanat, Ö., Günaldi, M., Serin, S. O., Saydaroğlu, Ö., Kumbasar, A., & Evrensel, T. (2015). Küçük hücreli akciğer kanserli hastalarda C-Kit (CD117) ekspresyonu (Expression de C-Kit (CD117) chez les patients atteints de cancer du poumon à petites cellules). Haseki Tıp Bülteni, 53, 67–71. https://doi.org/10.4274/haseki.2078
• Okuturlar, Y., Günaldi, M., Tiken, E. E., Tuna, S., Öztosun, B., Özdeminan, Y., Ercan, T., Harmankaya, Ö., & Kumbasar, A. (2015). Fazla kilo ve obezitenin meme kanseri alt tipleri üzerine etkisi (L'effet du surpoids et de l'obésité sur les sous-types de cancer du sein). Journal of Clinical and Analytical Medicine.
• Tiken, E. E., Günaldi, M., Okuturlar, Y., & Tuna, S. (2015). Senkron bilateral meme kanserli hastaların değerlendirilmesi (Évaluation des patientes atteintes de cancer du sein bilatéral synchrone). Istanbul Medical Journal. Advance online publication.
• Okuturlar, Y., Mert, M., Soyluk, Ö., Enki, S., Sayilan, S., Gönenç, M., Günaldi, M., Kumbasar, A., Aliş, H., & Harmankaya, Ö. (2015). İleri yaşta görülen nadir bir hipoglisemi nedeni: İnsülinoma (Une cause rare d'hypoglycémie chez les personnes âgées : Insulinome). Bakırköy Tıp Dergisi.
• Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Köksal Erkiş, M., Kara, İ. O., Şahin, B., & Gönlüsen, G. (2014). Osteosarkomların retrospektif değerlendirmesi (Évaluation rétrospective des ostéosarcomes). Journal of Clinical and Analytical Medicine.
• Günaldi, M. (2014). Meme kanseri risk faktörleri (Facteurs de risque du cancer du sein). Klinik Tıp Aile Hekimliği Dergisi.
• Özkara, İ. Ö., & Günaldi, M. (2014). Mide kanseri: Önleme, risk faktörleri ve prognoz (Cancer de l'estomac : Prévention, facteurs de risque et pronostic). Klinik Tıp Aile Hekimliği Dergisi.

Communications Présentées lors de Réunions Scientifiques et Publiées dans les Actes:

• Günaldı, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Kara, İ. O., Erkişi, M., & Şahin, B. (2012, March 21–25). Trastuzumab ilişkili kardiyotoksisiteye epirubisin ve doksorubisinin katkısının araştırılması (Étude de la contribution de l'épirubicine et de la doxorubicine à la cardiotoxicité liée au trastuzumab) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Günaldı, M., Paydaş, S., Afşar, Ç. U., Erçolak, V., Duman, B. B., & Doran, F. (2012, March 21–25). Tuberoskleroz ve malign melanom birlikteliği (Coexistence de la sclérose tubéreuse et du mélanome malin) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Günaldı, M. (2012, March 21–25). Bilateral over metastazı ile tanı konan primer appendiks adenokarsinomu (Adénocarcinome primitif de l'appendice diagnostiqué avec métastase ovarienne bilatérale) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Richter sendromu (Syndrome de Richter) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Duman, B. B., Afşar, Ç. U., Günaldı, M., Erkişi, M., Kara, İ. O., Şahin, B., & Kum, P. (2013, April 19–23). Meme kanserli hastalarda adjuvan/neoadjuvan kemoterapi deneyimimiz (Notre expérience de la chimiothérapie adjuvante/néoadjuvante chez les patientes atteintes de cancer du sein) [Présentation par Affiche]. 20. Ulusal Kanser Kongresi, Antalya, Turkey.
• Günaldı, M., Kara, İ. O., Afşar, Ç. U., Erçolak, V., & Duman, B. B. (2012, March 21–25). Akromegaliye eşlik eden malign mezankimal tümör (Tumeur mésenchymateuse maligne associée à l'acromégalie) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Erçolak, V., Paydaş, S., Şeydaoğlu, G., Günaldı, M., Afşar, Ç. U., & Duman, B. B. (2013). Hodgkin lenfoma olgularında retrospektif değerlendirme (Évaluation rétrospective des cas de lymphome de Hodgkin) [Présentation par Affiche]. 5. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Gunaldi, M., Okuturlar, Y., & Tiken, E. E. (2014, September). Geriatrik meme kanseri hastalarında moleküler alt grup değerlendirmesi (Évaluation des sous-groupes moléculaires chez les patientes gériatriques atteintes de cancer du sein) [Présentation par Affiche]. 1. Geriatri Onkoloji Kongresi, Antalya, Turkey.
• Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Akciğer adenokarsinomlu hastada alfa-2 globulin piki (Pic d'alpha-2 globuline chez un patient atteint d'adénocarcinome pulmonaire) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Duman, B. B., Şahin, B., Erkişi, M., Paydaş, S., Kara, İ. O., Afşar, Ç. U., Günaldı, M., Erçolak, V., & Kum, P. (2012, March 21–25). Metastatik renal hücreli karsinomda sitoredüktif nefrektominin sağkalım üzerine etkisi (L'effet de la néphrectomie citoréductrice sur la survie dans le carcinome rénal à cellules claires métastatique) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
• Günaldı, M., Şahin, B., Duman, B. B., Erçolak, V., & Afşar, Ç. U. (2012, March 21–25). Bevacizumab çene osteonekrozu için bir risk faktörü müdür? (Le bévacizumab est-il un facteur de risque pour l'ostéonécrose de la mâchoire ?) [Présentation par Affiche]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

• Association turque d'oncologie médicale (TTOD) – Conseil d'administration (2020-2022)
• Association interdisciplinaire d'oncologie (IDOD)
• Association turque de neuro-oncologie
• Société européenne d'oncologie médicale (ESMO)

• Prix du meilleur article du Dr Metin Karan (2013)
• Prix du meilleur article de la Société d'oncologie médicale (2012)
• Troisième prix du meilleur poster

• Cours sur les traitements biologiques de A à Z (2023)
• Cours de l'Association turque d'oncologie médicale (2020-2022)
• Congrès sur les soins palliatifs (2018)
• Symposium d'oncologie médicale d'Uludağ (2018)